Low dose interferon-alpha therapy for HIV-associated multicentric Castleman's disease.
Successful maintenance therapy with weekly interferon-alpha for HIV-associated multicentric Castleman's disease is described.
Nord
J A
JA
Section of Infectious Diseases, Department of Medicine, St Vincent's Hospital and Medical Center, New York, NY, USA. JillANord@AOL.COM
Karter
D
D
D000328:Adult; D005871:Castleman Disease / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011230:Precancerous Conditions / Q000188:drug therapy; D011379:Prognosis
D007155:Immunologic Factors; D016898:Interferon-alpha